Dear Research Colleagues,
As we indicated last week, we have seen a significant turnover of staff specifically in the clinical trial contracting team. Unfortunately, this will impact the turnaround time for CTAs, CDAs and MTAs in the near term. We are working hard to minimize the disruption to research activity and wanted to update you with the following information:
New Approach to Clinical Trial Agreements (CTAs)
New Process for Confidential Disclosure Agreements (CDAs)
We encourage all research teams to use the new partially executed CDA template that is now available on our Research Agreements page. The research team must complete the CDA template to include details of the sponsor and project and then send it to the sponsor.
Temporary Support for Material Transfer Agreements (MTAs)
Overall, we are currently slower than normal but thanks to everyone pulling together, we have been able to keep the workflow moving. Staffing shortages are currently affecting research institutions nationwide, and we are committed to doing everything we can to keep your important work moving forward with minimal disruptions.
Thank you for your patience as we work through this temporary slowdown.
Thomas Flaig, MD
Vice Chancellor of Research
Alison Lakin RN, LLB, LLM, PhD
Associate Vice Chancellor for Regulatory Compliance
And Research Integrity Officer
Please take a moment to visit and bookmark the newly launched website featuring limited funding opportunities.
To submit a proposal for these opportunities:
Interested candidates must send a one-page summary of their research proposal and their biosketch in pdf format via the Limited Submission Portal.
Fiscal Year 2022 (FY22) funding opportunities and pre-announcements for the Department of Defense (DoD) programs managed by the office of Congressionally Directed Medical Research Programs (CDMRP) are below.
CDMRP understands that applicants continue to be impacted by COVID-19. Submission deadlines for pre-applications and full applications will incorporate the maximum time that is feasible for each FY22 program.
FY22 Program Announcements released: Autism Research Program (ARP)
Orthotics and Prosthetics Outcomes Research Program (OPORP)
Ovarian Cancer Research Program (OCRP)
Spinal Cord Injury Research Program (SCIRP)
FY22 Pre-announcements released:
Tick-Borne Disease Research Program (TBDRP)
Letter of Intent (LOI) is due April 12, 2022. If your (LOI) has been approved by the committee chair, your full application is due by 5pm on Tuesday May 3, 2022
For questions or concerns please contact Peter Buttrick, MD, Senior Associate Dean for Academic Affairs; Andrew Fontenot, MD, SIRC Committee Chair; or Madison Avalos, Business Services Professional.
CMIR is currently accepting applications for Microgrant funding.
All CMIR members and trainee investigators from the CU-AMC or affiliated institutions are eligible to apply. Priority will be given to early career investigators (e.g., graduate students, postdoctoral research fellows and faculty at the rank of Assistant Professor or below who have not yet been awarded an R01 or equivalent grant).
Awards of up to $5,000 will be given per awarded Microgrant. Funds must be spent on CMIR services such as Research Core expertise and resources, sample access fees and data management/ statistical support. Microgrant projects should be structured to be completed in 12 months or less.
For questions on the application or review process, visit the website or contact Alyssa Haberle.
The CCTSI K to R (KTR) Transition and Pre-K programs are now accepting applications for review.
Both, Pre-K and K to R programs offer a unique opportunity for a Mock Study Section Review for those submitting NIH K and R grant applications.
Participants will receive specific written and verbal critique of their proposals prior to submission to the funding agency.
This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.
Past Research Bulletins can be found here.
Please click here if you wish to be added to this distribution.